• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主要冠状病毒疫情的临床特征、诊断与治疗

Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks.

作者信息

Mann Rupinder, Perisetti Abhilash, Gajendran Mahesh, Gandhi Zainab, Umapathy Chandraprakash, Goyal Hemant

机构信息

Department of Internal Medicine, Saint Agnes Medical Center, Fresno, CA, United States.

Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States.

出版信息

Front Med (Lausanne). 2020 Nov 13;7:581521. doi: 10.3389/fmed.2020.581521. eCollection 2020.

DOI:10.3389/fmed.2020.581521
PMID:33282890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7691433/
Abstract

Human coronavirus infections have been known to cause mild respiratory illness. It changed in the last two decades as three global outbreaks by coronaviruses led to significant mortality and morbidity. SARS CoV-1 led to the first epidemic of the twenty first century due to coronavirus. SARS COV-1 infection had a broad array of symptoms with respiratory and gastrointestinal as most frequent. The last known case was reported in 2004. Middle East respiratory syndrome coronavirus (MERS-CoV) led to the second outbreak in 2012, and case fatality was much higher than SARS. MERS-CoV has a wide array of clinical presentations from mild, moderate to severe, and some patients end up with acute respiratory distress syndrome (ARDS). The third and recent outbreak by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) started in December 2019, which lead to a global pandemic. Patients with SARS-CoV2 infection can be asymptomatic or have a range of symptoms with fever, cough, and shortness of breath being most common. Reverse transcriptase-Polymerase chain reaction (RT-PCR) is a diagnostic test of choice for SARS CoV-1, MERS-CoV, and SARS CoV-2 infections. This review aims to discuss epidemiological, clinical features, diagnosis, and management of human coronaviruses with a focus on SARS CoV-1, MERS-CoV, and SARS CoV-2.

摘要

已知人类冠状病毒感染会引起轻度呼吸道疾病。在过去二十年中,情况发生了变化,因为冠状病毒引发的三次全球疫情导致了重大的死亡率和发病率。严重急性呼吸综合征冠状病毒1型(SARS-CoV-1)引发了21世纪的首次冠状病毒疫情。SARS-CoV-1感染有一系列广泛的症状,其中呼吸道和胃肠道症状最为常见。最后一例已知病例于2004年报告。中东呼吸综合征冠状病毒(MERS-CoV)在2012年引发了第二次疫情,病死率远高于SARS。MERS-CoV有从轻度、中度到重度的广泛临床表现,一些患者最终会发展为急性呼吸窘迫综合征(ARDS)。第三次也是最近一次由严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)引发的疫情于2019年12月开始,导致了全球大流行。SARS-CoV-2感染患者可能无症状,或有一系列症状,最常见的是发热、咳嗽和呼吸急促。逆转录聚合酶链反应(RT-PCR)是SARS-CoV-1、MERS-CoV和SARS-CoV-2感染的首选诊断检测方法。本综述旨在讨论人类冠状病毒的流行病学、临床特征、诊断和管理,重点关注SARS-CoV-1、MERS-CoV和SARS-CoV-2。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a77/7691433/3cb036e40833/fmed-07-581521-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a77/7691433/91859adcb86f/fmed-07-581521-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a77/7691433/6c99f80e86d9/fmed-07-581521-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a77/7691433/3cb036e40833/fmed-07-581521-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a77/7691433/91859adcb86f/fmed-07-581521-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a77/7691433/6c99f80e86d9/fmed-07-581521-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a77/7691433/3cb036e40833/fmed-07-581521-g0003.jpg

相似文献

1
Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks.主要冠状病毒疫情的临床特征、诊断与治疗
Front Med (Lausanne). 2020 Nov 13;7:581521. doi: 10.3389/fmed.2020.581521. eCollection 2020.
2
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
3
Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.在新冠疫情早期,一家筛查诊所的冠状病毒病(COVID-19)病例的流行病学和临床特征:一项单中心研究。
J Med Microbiol. 2020 Aug;69(8):1114-1123. doi: 10.1099/jmm.0.001231.
4
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的生物学、临床和流行病学特征,以及 ACE2 的 AutoDock 模拟
Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6.
5
Current Strategies of Antiviral Drug Discovery for COVID-19.新型冠状病毒肺炎抗病毒药物研发的当前策略
Front Mol Biosci. 2021 May 13;8:671263. doi: 10.3389/fmolb.2021.671263. eCollection 2021.
6
Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.阿贝尔森激酶抑制剂是严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒融合的强效抑制剂。
J Virol. 2016 Sep 12;90(19):8924-33. doi: 10.1128/JVI.01429-16. Print 2016 Oct 1.
7
Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.儿童冠状病毒感染包括 COVID-19:儿童流行病学、临床特征、诊断、治疗和预防选择概述。
Pediatr Infect Dis J. 2020 May;39(5):355-368. doi: 10.1097/INF.0000000000002660.
8
Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.新型冠状病毒 2019-nCoV:流行情况、与 SARS-CoV 和 MERS-CoV 的生物学和临床特征比较。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2012-2019. doi: 10.26355/eurrev_202002_20379.
9
A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.新型冠状病毒表现的全面综述——在致命的 COVID-19 全球大流行背景下。
Am J Med Sci. 2020 Jul;360(1):5-34. doi: 10.1016/j.amjms.2020.05.006. Epub 2020 May 11.
10
Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.严重急性呼吸综合征与中东呼吸综合征。
Curr Opin Pulm Med. 2014 May;20(3):233-41. doi: 10.1097/MCP.0000000000000046.

引用本文的文献

1
Can major public health emergencies increase the participation of commercial insurance? Evidence from China.重大公共卫生事件能否增加商业保险参与度?来自中国的证据。
Front Public Health. 2024 May 23;12:1363451. doi: 10.3389/fpubh.2024.1363451. eCollection 2024.
2
Development of a robust TaqMan probe-based one-step multiplex RT-qPCR for simultaneous detection of SARS-CoV-2 and Influenza A/B viruses.建立一种基于 TaqMan 探针的一步法多重实时 RT-qPCR 方法,用于同时检测 SARS-CoV-2 和流感 A/B 病毒。
BMC Microbiol. 2023 Nov 11;23(1):335. doi: 10.1186/s12866-023-03048-9.
3
Analysis on the factors associated with COVID-19 infection among Chinese residents after the implementation of to optimize COVID-19 response: a cross-sectional study.

本文引用的文献

1
Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID).治疗性与预防性抗凝治疗重症 COVID-19:一项随机 II 期临床试验(HESACOVID)。
Thromb Res. 2020 Dec;196:359-366. doi: 10.1016/j.thromres.2020.09.026. Epub 2020 Sep 21.
2
Obesity a predictor of outcomes of COVID-19 hospitalized patients-A systematic review and meta-analysis.肥胖是 COVID-19 住院患者结局的预测因素:系统评价和荟萃分析。
J Med Virol. 2021 Feb;93(2):1188-1193. doi: 10.1002/jmv.26555. Epub 2020 Oct 7.
3
Clinical features and outcomes of adults with coronavirus disease 2019: A systematic review and pooled analysis of the literature.
实施“新 10 条”后中国居民 COVID-19 感染相关因素分析:一项横断面研究。
Front Public Health. 2023 Jun 8;11:1197889. doi: 10.3389/fpubh.2023.1197889. eCollection 2023.
4
Role and clinical implication of autophagy in COVID-19.自噬在 COVID-19 中的作用及临床意义。
Virol J. 2023 Jun 16;20(1):125. doi: 10.1186/s12985-023-02069-0.
5
Vitamin D, Albumin, and D-Dimer as Significant Prognostic Markers in Early Hospitalization in Patients with COVID-19.维生素D、白蛋白和D-二聚体作为COVID-19患者早期住院时的重要预后标志物
J Clin Med. 2023 Apr 12;12(8):2825. doi: 10.3390/jcm12082825.
6
Airway Epithelial Cell Junctions as Targets for Pathogens and Antimicrobial Therapy.气道上皮细胞连接作为病原体和抗菌治疗的靶点
Pharmaceutics. 2022 Nov 27;14(12):2619. doi: 10.3390/pharmaceutics14122619.
7
Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boosting.从西班牙流感到 COVID-19 的一个世纪呼吸道传染病的叙述性回顾,以及纳米技术对 COVID-19 诊断和免疫系统增强的影响。
Virol J. 2022 Oct 24;19(1):167. doi: 10.1186/s12985-022-01902-2.
8
Clinical Performance of Rapid Antigen Tests for the Detection of SARS-CoV-2 Infection in the Emergency Department and Community: A Retrospective Study.急诊科和社区中快速抗原检测用于检测SARS-CoV-2感染的临床性能:一项回顾性研究
Can J Infect Dis Med Microbiol. 2022 Oct 6;2022:9447251. doi: 10.1155/2022/9447251. eCollection 2022.
9
A jejunal gastrointestinal stromal tumor with massive gastrointestinal hemorrhage treated by emergency surgery: A case report.急诊手术治疗的巨大胃肠道出血的空肠胃肠道间质瘤:一例报告。
Medicine (Baltimore). 2022 Sep 2;101(35):e30098. doi: 10.1097/MD.0000000000030098.
10
Insights into COVID-19 vaccines development: Translation from benchside to bedside.对2019冠状病毒病疫苗研发的洞察:从实验室到临床的转化
Health Sci Rev (Oxf). 2022 Sep;4:100040. doi: 10.1016/j.hsr.2022.100040. Epub 2022 Jul 10.
新型冠状病毒病 2019 成人的临床特征和结局:文献的系统评价和汇总分析。
Int J Clin Pract. 2021 Mar;75(3):e13725. doi: 10.1111/ijcp.13725. Epub 2020 Nov 3.
4
Systematic Review and Meta-analysis of Smell and Taste Disorders in COVID-19.新型冠状病毒肺炎嗅觉和味觉障碍的系统评价与荟萃分析
OTO Open. 2020 Sep 11;4(3):2473974X20957975. doi: 10.1177/2473974X20957975. eCollection 2020 Jul-Sep.
5
Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study.COVID-19 重症患者的血栓和出血并发症:一项多中心观察研究。
Crit Care. 2020 Sep 18;24(1):561. doi: 10.1186/s13054-020-03260-3.
6
Epidemiologic, clinical, and laboratory findings of the COVID-19 in the current pandemic: systematic review and meta-analysis.新型冠状病毒肺炎大流行期间的流行病学、临床和实验室研究结果:系统评价和荟萃分析。
BMC Infect Dis. 2020 Aug 31;20(1):640. doi: 10.1186/s12879-020-05371-2.
7
Thrombosis in COVID-19.COVID-19 相关血栓形成。
Am J Hematol. 2020 Dec;95(12):1578-1589. doi: 10.1002/ajh.25982. Epub 2020 Sep 16.
8
One-Seventh of Patients with COVID-19 Had Olfactory and Gustatory Abnormalities as Their Initial Symptoms: A Systematic Review and Meta-Analysis.七分之一的新冠病毒肺炎患者以嗅觉和味觉异常为首发症状:一项系统评价与荟萃分析
Life (Basel). 2020 Aug 22;10(9):158. doi: 10.3390/life10090158.
9
Management of Thrombotic Complications in COVID-19: An Update.COVID-19 相关血栓并发症的管理:最新进展。
Drugs. 2020 Oct;80(15):1553-1562. doi: 10.1007/s40265-020-01377-x.
10
Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes.COVID-19 流行病学:临床特征、危险因素和结局的系统评价和荟萃分析。
J Med Virol. 2021 Mar;93(3):1449-1458. doi: 10.1002/jmv.26424. Epub 2020 Aug 25.